Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome (Q90862879)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

review article

1 reference

title

Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

author name string

Ziying Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

Haosheng Tang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

Peng Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

Hui Xie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

Yongguang Tao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

publication date

12 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

page(s)

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

Microbiome as a therapeutic target in alcohol-related liver disease

17 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A human gut microbial gene catalogue established by metagenomic sequencing

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Finishing the euchromatic sequence of the human genome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

New insights from uncultivated genomes of the global human gut microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A new genomic blueprint of the human gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Structural variation in the gut microbiome associates with host health

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiosis in pathogenesis and intervention of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Regulation of MicroRNA Machinery and Development by Interspecies S-Nitrosylation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Critical Role for the Microbiota in CX3CR1 Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Human Intestinal Microbiome in Health and Disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer's Disease using 16S rRNA gene and metagenomic sequencing analysis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Mapping human microbiome drug metabolism by gut bacteria and their genes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt Regulatory T Cells and Exacerbate Colitis in Mice.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiota and colon cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The neuroactive potential of the human gut microbiota in quality of life and depression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

TMAO and Heart Disease: The New Red Meat Risk?

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome metabolomics reveals new drivers of human liver steatosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lactobacillus rhamnosus GG-Derived Soluble Mediators Modulate Adaptive Immune Cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Distinct Microbial Communities Trigger Colitis Development upon Intestinal Barrier Damage via Innate or Adaptive Immune Cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Shaping of Intestinal Microbiota in Nlrp6- and Rag2-Deficient Mice Depends on Community Structure

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anaerostipes butyraticus sp. nov., an anaerobic, butyrate-producing bacterium from Clostridium cluster XIVa isolated from broiler chicken caecal content, and emended description of the genus Anaerostipes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A new colitis therapy strategy via the target colonization of magnetic nanoparticle-internalized Roseburia intestinalis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Short chain fatty acids in human large intestine, portal, hepatic and venous blood

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbial metabolite sensor GPR43 controls severity of experimental GVHD

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Common Mechanism Links Activities of Butyrate in the Colon

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

To respond or not to respond - a personal perspective of intestinal tolerance.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Mining the microbiota for microbial and metabolite-based immunotherapies

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells' Differentiation and Function in Induction of Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8 T Cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbial Metabolites Fuel Host Antibody Responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

B cell-helping functions of gut microbial metabolites

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin through GPR43

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Host Selection of Microbiota via Differential Adhesion.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota utilize immunoglobulin A for mucosal colonization

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbial metabolite butyrate facilitates M2 macrophage polarization and function

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome control of innate reactivity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Colonocyte metabolism shapes the gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Host-derived nitrate boosts growth of E. coli in the inflamed gut

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Nod-Like Receptor Pyrin-Containing Protein 6 (NLRP6) Is Up-regulated in Ileal Crohn's Disease and Differentially Expressed in Goblet Cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor-Dependent Repression of Claudin-2.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Potential of butyrate to influence food intake in mice and men.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbial metabolites in obesity, NAFLD and T2DM

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Disruption of Epithelial HDAC3 in Intestine Prevents Diet-induced Obesity in Mice.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Drosophila Immune Deficiency Pathway Modulates Enteroendocrine Function and Host Metabolism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Host microbiota constantly control maturation and function of microglia in the CNS.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Butyrate suppresses demyelination and enhances remyelination

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiota influences blood-brain barrier permeability in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary Fiber Confers Protection against Flu by Shaping Ly6c- Patrolling Monocyte Hematopoiesis and CD8 T Cell Metabolism.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbial tryptophan catabolites in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Alpinetin exerts anti-colitis efficacy by activating AhR, regulating miR-302/DNMT-1/CREB signals, and therefore promoting Treg differentiation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Feedback control of AHR signalling regulates intestinal immunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lactobacillus reuteri induces gut intraepithelial CD4 CD8αα T cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Indole Signaling at the Host-Microbiota-Pathogen Interface

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbiota metabolite indole inhibits Salmonella virulence: Involvement of the PhoPQ two-component system

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bacteria Tell Us How to Protect Our Intestine

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microglial control of astrocytes in response to microbial metabolites.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Brain inflammatory cascade controlled by gut-derived molecules

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Regulating inflammation with microbial metabolites.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiota metabolite indole alleviates liver inflammation in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Microbial Drugstore for Motility

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal bacteria make GPCR ligands that mimic human signalling molecules

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-derived Metabolic Factors Reduce Campylobacteriosis in Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal Bile Acids Induce a Morphotype Switch in Vancomycin-Resistant Enterococcus that Facilitates Intestinal Colonization

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

FXR Regulates Intestinal Cancer Stem Cell Proliferation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome: the bacterial tightrope

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cancer immunity thwarted by the microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4 T-Cell-Dependent Control of Senescence

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Accumulation of succinate controls activation of adipose tissue thermogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

An unexpected trigger for calorie burning in brown fat

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cecal succinate elevated by some dietary polyphenols may inhibit colon cancer cell proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Tuft Cell-ILC2 Circuit Integrates Intestinal Defense and Homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Getting a Taste for Parasites in the Gut

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Succinate receptor mediates intestinal inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Succinate is an inflammatory signal that induces IL-1β through HIF-1α.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

GPR31-dependent dendrite protrusion of intestinal CX3CR1 cells by bacterial metabolites

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Probiotic strains detect and suppress cholera in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Derived Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial Development

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Derived Lactate Activates Production of Reactive Oxygen Species by the Intestinal NADPH Oxidase Nox and Shortens Drosophila Lifespan

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Accessing Bioactive Natural Products from the Human Microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal microbiota promote enteric virus replication and systemic pathogenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

https://api.crossref.org/works/10.1038/S41392-019-0074-5

1 reference

7 January 2021

A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A gut punch fights cancer and infection

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Compartmentalized gut lymph node drainage dictates adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3 regulatory CD4 T cells in an interleukin-10-dependent manner

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Inducible Foxp3 regulatory T-cell development by a commensal bacterium of the intestinal microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Foxp3( ) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Extrathymically Generated Regulatory T Cells Establish a Niche for Intestinal Border-Dwelling Bacteria and Affect Physiologic Metabolite Balance.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host-microbiota homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

What Came First: The Microbiota or the Tr(egg) Cells?

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Subcellular antigen localization in commensal E. coli is critical for T cell activation and induction of specific tolerance

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39( )Foxp3( ) T cells and Treg function

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A microbial symbiosis factor prevents intestinal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Autophagy: Suicide Prevention Hotline for the Gut Epithelium

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Host-microbiota interactions and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal bacteria protect against food allergen sensitization

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Role of Lactobacillus reuteri in Human Health and Diseases.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cell surface polysaccharides of induce the generation of Foxp3 regulatory T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbiota in adaptive immune homeostasis and disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Induction of intestinal Th17 cells by segmented filamentous bacteria

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

ATP drives lamina propria T(H)17 cell differentiation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Focused specificity of intestinal TH17 cells towards commensal bacterial antigens

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Salt-responsive gut commensal modulates TH17 axis and disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Notch regulates IL-10 production by T helper 1 cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Nutrients Mediate Intestinal Bacteria-Mucosal Immune Crosstalk

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

CCL28-Deficient Mice Have Reduced IgA Antibody-Secreting Cells and an Altered Microbiota in the Colon.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Epithelial endoplasmic reticulum stress orchestrates a protective IgA response

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Segmented Filamentous Bacteria - Metabolism Meets Immunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Defective IgA response to atypical intestinal commensals in IL-21 receptor deficiency reshapes immune cell homeostasis and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The molecular mechanism for activating IgA production by Pediococcus acidilactici K15 and the clinical impact in a randomized trial.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal Microbes Induce Serum IgA Responses that Protect against Polymicrobial Sepsis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbiome and autoimmunity: a paradigm from the gut-liver axis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

High-avidity IgA protects the intestine by enchaining growing bacteria

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

FcαRI co-stimulation converts human intestinal CD103 dendritic cells into pro-inflammatory cells through glycolytic reprogramming.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Nutrient Sensing in CD11c Cells Alters the Gut Microbiota to Regulate Food Intake and Body Mass

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota: IgA Protects the Pioneers

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Antibodies that lIgAte our intestinal microbes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate lymphoid cells regulate CD4 T-cell responses to intestinal commensal bacteria

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Immunology. The axis of tolerance.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

ILC3s and the Willow Tree of Voices

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate lymphoid cells regulate intestinal epithelial cell glycosylation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Interleukin-22 protects intestinal stem cells against genotoxic stress

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Prostaglandin E₂ constrains systemic inflammation through an innate lymphoid cell-IL-22 axis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Induction of autophagy in Cx3cr1 mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

-induced matrix metallopeptidase-10 promotes gastric bacterial colonization and gastritis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

LAG3 Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1 Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota dysbiosis in select human cancers: Evidence of association and causality

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Helicobacter pylori infection and pancreatic cancer risk: A meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbiota and microbiome in pancreatic cancer: more influential than expected

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Gut Microbiome in Pancreatic Disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cancer statistics, 2019

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Burden of liver diseases in the world

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Cytolethal Distending Toxin Subunit CdtB of Helicobacter Induces a Th17-related and Antimicrobial Signature in Intestinal and Hepatic Cells In Vitro

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Cytolethal Distending Toxin Subunit CdtB of Helicobacter hepaticus Promotes Senescence and Endoreplication in Xenograft Mouse Models of Hepatic and Intestinal Cell Lines.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiome and liver cancer: mechanisms and clinical translation.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Molecular Targets in Hepatocarcinogenesis and Implications for Therapy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-κB Signaling Pathway Inhibition in Bile Duct-Ligated Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bile Acids, the Microbiome, Immunity, and Liver Tumors

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cancer treatment and survivorship statistics, 2019

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Breast cancer in postmenopausal women is associated with an altered gut metagenome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Antibiotic use in relation to the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Risk of breast cancer in relation to antibiotic use

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A pilot study of male breast cancer in the Veterans Affairs healthcare system

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States).

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut bacteria require neutrophils to promote mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A joint analysis of metabolomics and genetics of breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiome and malignancy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Effects of phytoestrogens on the activity and growth of primary breast cancer cells ex vivo

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Naturally Lignan-Rich Foods: A Dietary Tool for Health Promotion?

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial–mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Unearthing roles for the gut microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Elements of cancer immunity and the cancer-immune set point

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cancer immunotherapy using checkpoint blockade.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anti-CTLA-4 immunotherapy does not deplete FOXP3 regulatory T cells (Tregs) in human cancers

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The microbiome, cancer, and cancer therapy

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Environment dominates over host genetics in shaping human gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

US Immigration Westernizes the Human Gut Microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The intestinal microbiota regulates body composition through NFIL3 and the circadian clock.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Six-Week Endurance Exercise Alters Gut Metagenome That Is not Reflected in Systemic Metabolism in Over-weight Women

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Extensive impact of non-antibiotic drugs on human gut bacteria.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota and cancer immunotherapy: in search of microbial signals

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Duodenal infusion of donor feces for recurrent Clostridium difficile

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fecal microbiota transplantation in cancer management: Current status and perspectives

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Modulating the microbiome to improve therapeutic response in cancer

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Clinical Application and Potential of Fecal Microbiota Transplantation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Searching for superstool: maximizing the therapeutic potential of FMT

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Weight gain after fecal microbiota transplantation

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The cancer microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Antibiotics-induced monodominance of a novel gut bacterial order

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Bacterial viability in faecal transplants: Which bacteria survive?

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Role of the gut microbiota in nutrition and health.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

A randomized synbiotic trial to prevent sepsis among infants in rural India

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Probiotics and the Prevention of Antibiotic-Associated Diarrhea in Infants and Children

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Pathogen elimination by probiotic Bacillus via signalling interference

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

An exclusive metabolic niche enables strain engraftment in the gut microbiota

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Butyrate and Dietary Soluble Fiber Improve Neuroinflammation Associated With Aging in Mice

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Genetically modified bacteria enlisted in fight against disease

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota phenotypes of obesity

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut Microbes May Account for the Anti-Seizure Effects of the Ketogenic Diet

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production.

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Transforming medicine with the microbiome

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

The gut microbiota at the intersection of diet and human health

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

1 reference

https://api.crossref.org/works/10.1038/S41392-019-0074-5

7 January 2021

10.1038/S41392-019-0074-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31637019 AND SRC:MED&resulttype=core&format=json

17 April 2020

PubMed publication ID

31637019

1 reference